Gentry Haughton, DPM
Foot & Ankle Surgery · Shreveport, LANPI 1316171358
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,258 of the $9,719 with a category attached, or 85.0%. 11 manufacturers reported payments, led by Convatec Inc. at 30.0% of the total. Reporting peaked in 2024 at $3,119 and has fallen 62.5% since, to $1,171 in 2025.
Across 231 payments — averaging $42.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$3K
- Organogenesis Inc.$2K
- AbbVie$2K
- Melinta Therapeutics, LLC$1K
- Kerecis Limited$723
- Paratek Pharmaceuticals, Inc.$492
- plus $223 from 5 others
What the payments were for
- Travel & lodging$1,46215%
- Food & beverage$8,25885%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 30 | $2,912 |
| Organogenesis Inc. | 54 | $2,070 |
| AbbVie(2 entities) | 99 | $1,805 |
| Melinta Therapeutics, LLC | 31 | $1,493 |
| Kerecis Limited | 5 | $723 |
| Paratek Pharmaceuticals, Inc. | 5 | $492 |
| Smith+Nephew | 1 | $124 |
| Integra Lifesciences Corporation | 3 | $50 |
| Mimedx Group, Inc. | 1 | $18 |
| Vertex | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$1,402
- Kerecis Omega3 Marigen$1,149
- Kerecis Omega3 SurgiClose$1,013
- Kerecis Omega3 GraftGuide$541
- Kimyrsa$488
- NUZYRA$471
- DALVANCE$365
- Baxdela$125
- Orbactiv$125
- Rezzayo$125
- Santyl$124
- REGRANEX$124
- Oasis$124
How this compares
$9,719 in reported general payments places this provider in the 80th percentile of 92 foot & ankle surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 262 | $8,088 |
| Gabapentin | 619 | $5,323 |
| Clobetasol Propionate | 60 | $4,870 |
| Terbinafine Hcl | 414 | $3,805 |
| Duloxetine Hcl | 206 | $3,222 |
| Diclofenac Sodium | 26 | $1,053 |
| Doxycycline Hyclate | 69 | $656 |
| Meloxicam | 108 | $394 |
| Clotrimazole | 18 | $295 |
| Fluconazole | 11 | $213 |
| Silver Sulfadiazine | 13 | $115 |
| Clindamycin Hcl | 13 | $96 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $52 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Shreveport
- Henrique HilarioShreveport$14K
- Gabriel MitchellShreveport$5K
- William AndressShreveport$3K
- Rebecca McGahaShreveport$1K
- Brian BensonLeesville$278K
- Meredith WarnerBaton Rouge$232K
- Tyson GreenLake Charles$203K
- Bryon McKennaThibodaux$131K
- Mohamad IssaNew Orleans$24K
- Leon WatkinsMetairie$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.